U.S. Stock News

VEON (NasdaqGS:VEON) is expanding its digital and cybersecurity operations in Uzbekistan with a new network operations center and the launch of BuildX, a software development and AI company. The company is also preparing a U.S. public offering of shares in its Ukrainian subsidiary Kyivstar, following preliminary results that indicate substantial annual growth under challenging geopolitical conditions. Together, these steps mark a material shift in VEON's regional footprint and could...

Wix.com (WIX) is back on investors’ radar after its new AI website builder, Wix Harmony, sparked a sharp shift in sentiment by pairing natural language prompts with full visual editing and enterprise-focused stability. See our latest analysis for Wix.com. That product story is now intersecting with the share price in a meaningful way. The recent launch of Wix Harmony and the newly authorized US$2b buyback program arrive after a stretch that includes a 30 day share price return of 13.01% and a...

If you are wondering whether Accenture's current share price really reflects what the business is worth, you are in the right place for a closer look at value. Accenture recently closed at US$261.22, with a 7 day return of 8.4% decline, a 30 day return of 3.3% decline, and a 1 year return of 29.9% decline. This sets an interesting backdrop for a stock that is roughly flat year to date at 0.5% and up 11.9% over 5 years. Recent headlines around Accenture have focused on its role as a major...

International Business Machines (IBM) closed out FY 2025 with fourth quarter revenue of US$19.7b and basic EPS of US$5.96, while trailing twelve month EPS came in at US$11.34 alongside net income from continuing operations of US$10.57b. Over recent quarters the company has seen revenue move from US$17.6b in Q4 2024 to US$14.5b in Q1 2025, US$17.0b in Q2 2025 and US$16.3b in Q3 2025, with basic EPS ranging from US$1.14 to US$5.96 across the same stretch, highlighting a story in which changes...

PDD Holdings (NasdaqGS:PDD) is facing heightened regulatory scrutiny in China in 2026, as authorities continue sector wide probes. The company is caught up in broader investigations into internet platforms, including food delivery services and anti monopoly actions. Recent analyst commentary has flagged regulatory risk as a key issue for PDD Holdings and the wider Chinese internet sector. PDD Holdings, the owner of discount ecommerce platform Pinduoduo and global site Temu, now sits in the...

Fifth Third Bancorp recently reported fourth-quarter 2025 results showing higher net interest income of US$1,529 million and net income of US$731 million, while also disclosing lower net charge-offs of US$125 million compared with a year earlier. Management highlighted that integration of Comerica is running ahead of schedule, with expected earnings-per-share benefits now targeted earlier than initially planned and supported by growth in commercial payments, technology investments and...

Terrestrial Energy, ticker NasdaqGS:IMSR, has executed an Other Transaction Authority agreement with the U.S. Department of Energy for Project TEFLA. The TEFLA project focuses on producing IMSR Fuel Salt and advancing domestic nuclear fuel capabilities for next generation reactors. This OTA framework is intended to support the commercial readiness of Terrestrial Energy's IMSR plants and deepen its collaboration with the DOE. Terrestrial Energy enters this agreement with the DOE as its...

Houlihan Lokey (HLI) reported a busy quarter, with Q3 2026 revenue of US$717.1 million and basic EPS of US$1.75, supported by trailing 12 month EPS of US$6.73 and net income of US$447.8 million on revenue of US$2.6 billion. Over recent quarters the company’s revenue has increased from US$574.9 million and EPS of US$1.42 in Q2 2025 to US$717.1 million and EPS of US$1.75 in Q3 2026. Over the same period, trailing 12 month EPS rose from US$5.15 to US$6.73 and net income from US$334.4 million to...

If you are wondering whether Lamb Weston Holdings is attractively priced today, it helps to step back and look at what the recent share performance and fundamentals are really telling you about value. The stock last closed at US$45.96, with returns of 4.2% over the past 7 days, 9.6% over 30 days, 8.7% year to date, but a 22.9% decline over 1 year and a 49.7% decline over 3 years. This can change how investors think about its risk and return profile. Recent coverage of Lamb Weston has focused...

For investors wondering if Scotts Miracle-Gro at around US$65 a share still offers value, or if the easy money has already been made, this article is designed to address that question directly. The stock has recently posted returns of 5.0% over 7 days, 13.4% over 30 days and 10.1% year to date. However, the past 1 year, 3 year and 5 year returns of 4.8%, 11.5% and 67.1% declines present a different side of the story. These mixed returns reflect a period in which investors continue to...

Greif (NYSE:GEF) approved a new $300 million share repurchase authorization. The company reported leverage at historically low levels after recent debt reduction efforts. Greif plans to sell a timberland portfolio, with proceeds expected to be used for further debt reduction. Greif, a global producer of industrial packaging and related services, operates at the intersection of manufacturing, logistics, and materials handling, areas that often track broader industrial activity. For...

In recent weeks, StoneCo has drawn attention as analysts highlighted expectations for year-over-year earnings growth of over 28% ahead of its March 2, 2026 results, even as it currently carries a Zacks Rank of #4 (Sell) and trades at a discount to its industry on a forward P/E basis. An interesting aspect is that, despite this cautious quantitative ranking, major houses such as UBS and Goldman Sachs continue to reiterate positive views on StoneCo’s business prospects, underscoring a clear...

If you are wondering whether Itron is fairly priced or offering value right now, you are not alone. The starting point is to understand what the recent share performance is really telling you. The stock last closed at US$100.19, with returns of 0.5% over the past week, 6.3% over the past month, 6.1% year to date, and a 6.8% decline over the past year. The 3 year return sits at 67.3% and the 5 year return at 1.7%. Recent coverage of Itron has focused on its role in providing technology for...

If you are looking at CSX and wondering whether the current share price offers good value, the key question is how that price compares with what the business might reasonably be worth. CSX shares last closed at US$37.87, with returns of 5.8% over the past week, 4.0% over the past month, 4.4% year to date, 17.1% over 1 year, 21.2% over 3 years and 37.4% over 5 years, which puts recent moves in the context of a longer track record. Recent market attention on CSX has been shaped by ongoing...

Stride (LRN) has just posted Q2 2026 results with revenue of US$631.3 million and basic EPS of US$2.31, while trailing twelve month revenue sits at about US$2.5 billion and EPS at US$7.39. Over recent quarters, revenue has moved from US$587.2 million and EPS of US$2.24 in Q2 2025 to US$631.3 million and EPS of US$2.31 in Q2 2026. The trailing net profit margin is 12.7% compared to 12.3% a year earlier, which points to slightly firmer profitability. Taken together, these figures present a...

If you are wondering whether Bausch + Lomb shares offer good value at today's price, it helps to start by looking at what the market has been willing to pay for them recently and how that lines up with the fundamentals we can see. The stock closed at US$16.85 most recently, with a 2.0% decline over the last week, a 1.8% decline over the last month, a 1.6% gain year to date, and a 4.5% decline over the past year. Together, these figures give you a mixed picture of how sentiment has shifted...

If you are wondering whether Biogen's current share price offers good value or if you might be paying too much for its future potential, this article walks through what the numbers are actually saying. Biogen shares closed at US$176.18, with returns of 2.7% over the last 7 days, 0.1% over 30 days, a 0.9% decline year to date, a 22.4% return over 1 year, a 37.9% decline over 3 years and a 33.5% decline over 5 years. This gives a mixed picture for investors weighing recent momentum against...

If you are wondering whether First Horizon's current share price lines up with its underlying worth, you are not alone, and that is exactly what this article will unpack. The stock most recently closed at US$24.42, with returns of 1.2% year to date and 14.5% over the last year. Over the past 5 years it shows a 91.2% return, with a 7 day move of a 0.9% decline and a 30 day return of 2.1%. Recent coverage around First Horizon has focused on its position within the US regional banking sector...

If you are wondering whether Tenet Healthcare's current share price still offers value, this article walks through what the numbers say and how to think about the stock in practical terms. Tenet Healthcare recently closed at US$189.49, with a flat 7 day return, a 5.9% decline over 30 days, a 5.0% decline year to date, and longer term returns of 32.3% over 1 year, 227.5% over 3 years and 280.0% over 5 years. Recent coverage of Tenet Healthcare has focused on its position as a large US...

Concentra Group Holdings Parent (CON) has drawn attention after reporting preliminary Q4 and full year 2025 results that exceeded its earlier guidance, along with fresh 2026 outlook figures and updated investor materials. See our latest analysis for Concentra Group Holdings Parent. The latest guidance and buyback update come after a period where the 30 day share price return of 8.22% and year to date share price return of 11.28% contrast with a 1 year total shareholder return decline of...

If you are wondering whether PTC at around US$153 per share still makes sense for your portfolio, it helps to look closely at what the current price might be implying about the company. The stock has seen a 6.8% decline over the last 7 days, a 12.5% decline over 30 days and is down 9.8% year to date, with a 20.1% decline over the last year, although the 3 year and 5 year returns sit at 16.0% and 10.2% respectively. These moves come as investors continue to reassess software names in general...

Carpenter Technology (CRS) opened Q2 2026 with total revenue of US$728 million, basic EPS of US$2.10 and net income excluding extra items of US$105.3 million. This put fresh numbers on a year in which trailing twelve month EPS reached US$8.67 on revenue of US$2.9 billion and net income of US$434.7 million. Over the past year, the company has seen quarterly revenue move from US$676.9 million in Q2 2025 to US$728 million in Q2 2026, while basic EPS stepped up from US$1.67 to US$2.10 and...

CSG Systems International (NasdaqGS:CSGS) has extended its multi year contract with DISH Network to provide billing and payment platform services. The agreement continues a decades long relationship and is set to run through 2030. The renewal supports DISH Network’s customer experience goals while keeping CSG at the core of its connectivity operations. For investors watching NasdaqGS:CSGS, this long term renewal with a major client comes as the stock trades at $79.65, with a 1 year return...

Perspective Therapeutics recently reported updated interim data from its ongoing Phase 1/2a trial of lead radiopharmaceutical candidate VMT-α-NET, indicating sustained anti-tumor activity, and issued a business update outlining clinical priorities and manufacturing expansion plans. This combination of early clinical signals and investment in production capacity highlights how the company is positioning VMT-α-NET as a core asset in its radiopharmaceutical pipeline. We’ll now examine how the...